Factors associated with serum CA125 level in women without ovarian cancer in the United States: a population-based study

BACKGROUND: Cancer antigen 125 (CA125) is clinically used to monitor response to therapy in ovarian cancer and has been proposed for use in detecting ovarian cancer. This population-based study examines how demographic characteristics, gynecologic/reproductive history, chronic non-malignant medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiao, Zhang, Jingzhou, Cao, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107191/
https://www.ncbi.nlm.nih.gov/pubmed/35568827
http://dx.doi.org/10.1186/s12885-022-09637-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107191/
https://www.ncbi.nlm.nih.gov/pubmed/35568827
http://dx.doi.org/10.1186/s12885-022-09637-7

Ejemplares similares